DLL3-expressing Tumors
Oncology·MeSH: Neoplasms
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| hpn328 | Harpoon Therapeutics, Inc. (HARP) |
Frequently asked questions
How many drugs are in development for DLL3-expressing Tumors?
BioSniper tracks 1 drug in development for DLL3-expressing Tumors across 1 company.
How many clinical trials target DLL3-expressing Tumors?
There are 1 clinical trial targeting DLL3-expressing Tumors tracked by BioSniper.
Deep-dive into DLL3-expressing Tumors
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis